China National Medicines Corporation Ltd.
600511
Peringkat dalam Saham
#4955
China National Medicines Corporation Ltd., in conjunction with its various... China National Medicines Corporation Ltd., in conjunction with its various operating entities, is a prominent player in the distribution of pharmaceutical goods across China. The enterprise's scope extends to the production and commercialization of innovative as well as pre-existing drug formulations. Additionally, it markets both traditional Chinese patent remedies and modern Western medications, alongside a range of medical apparatus. Complementing these activities, the firm delivers warehousing solutions and acts as an agent for import and export transactions. Its diverse clientele encompasses hospitals, retail pharmacies, and other healthcare organizations. Established in 1999, the company maintains its principal office in Beijing, China.
Harga Saham
$3.90
Kapitalisasi Pasar
$2.94B
Perubahan (1 hari)
-1.46%
Perubahan (1 tahun)
-3.02%
Negara
CN
Perdagangan China National Medicines Corporation Ltd. (600511)
Kategori
Healthcare
Laba untuk China National Medicines Corporation Ltd. (600511)
Laba pada Jun 2026 TTM: $364.66M
Menurut laporan keuangan terbaru dari China National Medicines Corporation Ltd., laba saat ini perusahaan adalah $364.66M. Pada tahun 2023, perusahaan memperoleh laba sebesar $414.05M, peningkatan dibandingkan laba tahun 2022 sebesar $389.67M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk China National Medicines Corporation Ltd. dari 2000 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $364.66M | 0.30% |
| 2024 | $363.55M | -12.20% |
| 2023 | $414.05M | 6.26% |
| 2022 | $389.67M | 1.30% |
| 2021 | $384.65M | 31.06% |
| 2020 | $293.50M | -15.78% |
| 2019 | $348.48M | 18.48% |
| 2018 | $294.13M | 9.94% |
| 2017 | $267.54M | 18.23% |
| 2016 | $226.29M | 120.07% |
| 2015 | $102.83M | 1.91% |
| 2014 | $100.90M | 15.95% |
| 2013 | $87.02M | 28.00% |
| 2012 | $67.98M | 4.71% |
| 2011 | $64.92M | 26.10% |
| 2010 | $51.48M | 19.05% |
| 2009 | $43.24M | 17.69% |
| 2008 | $36.75M | 38.38% |
| 2007 | $26.56M | 79.82% |
| 2006 | $14.77M | 65.07% |
| 2005 | $8.95M | 30.75% |
| 2004 | $6.84M | 4.66% |
| 2003 | $6.54M | 21.97% |
| 2002 | $5.36M | 27.10% |
| 2001 | $4.22M | 35.00% |
| 2000 | $3.12M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $6.46B | 1,670.97% |
US
|
|
| - | - |
US
|
|
| $2.17B | 496.17% |
US
|
|
| - | - |
US
|
|
| $708.86M | 94.39% |
AU
|
